Research Topics
| Joel A SimonSummaryAffiliation: University of California Country: USA Publications
| Collaborators
|
Detail Information
Publications
Sustained-release bupropion for hospital-based smoking cessation: a randomized trialJoel A Simon
General Internal Medicine Section 111A1, Medical Service, Department of Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
Nicotine Tob Res 11:663-9. 2009..Bupropion is a first-line pharmacological aid for smoking cessation; however, no clinical trials have been conducted in a general population of hospitalized smokers...- The relation of alpha-linolenic acid to the risk of prostate cancer: a systematic review and meta-analysisJoel A Simon
General Internal Medicine Section, Medical Service, Veterans Affairs Medical Center, San Francisco, CA, USA
Am J Clin Nutr 89:1558S-1564S. 2009..alpha-Linolenic acid (ALA; 18:3n-3) has been associated inconsistently with an increased risk of prostate cancer. Additional studies have become available since the publication of 2 previous meta-analyses... 
Lack of effect of walnuts on serum levels of prostate specific antigen: a brief reportJoel A Simon
General Internal Medicine 111A1, San Francisco VA Medical Center, 4150 Clement Street, San Francisco, California 94121, USA
J Am Coll Nutr 26:317-20. 2007..To examine whether the short-term consumption of walnuts, a food rich in alpha-linolenic acid, affects levels of serum prostate-specific antigen (PSA), a marker of prostate enlargement, inflammation, and cancer...- Hypnosis for smoking cessation: a randomized trialTimothy P Carmody
San Francisco Veterans Affairs Medical Center, University of California, San Francisco, CA, USA
Nicotine Tob Res 10:811-8. 2008..It was concluded that hypnosis combined with NP compares favorably with standard behavioral counseling in generating long-term quit rates... - Bupropion for smoking cessation: a randomized trialJoel A Simon
General Internal Medicine Section, Medical Service, San Francisco Veterans Affairs Medical Center, San Francisco, CA 94121, USA
Arch Intern Med 164:1797-803. 2004..Bupropion hydrochloride is recommended for smoking cessation; however, there have been relatively few clinical trials examining its efficacy... 
Expectancies regarding the interaction between smoking and substance use in alcohol-dependent smokers in early recoveryTimothy P Carmody
Mental Health Service, San Francisco VA Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
Psychol Addict Behav 26:358-63. 2012....- Intensive intervention for alcohol-dependent smokers in early recovery: a randomized trialTimothy P Carmody
Mental Health Service, San Francisco VA Medical Center, CA 94121, USA
Drug Alcohol Depend 122:186-94. 2012..The purpose of this study was to investigate the efficacy of an intensive tobacco cessation intervention for alcohol-dependent smokers in early recovery... - Bupropion for smoking cessation: a reviewElisa K Tong
Division of General Internal Medicine and Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, CA, USA
Compr Ther 32:26-33. 2006..Bupropion is the only antidepressant recommended as first-line pharmacotherapy for smoking cessation. Bupropion is as effective as nicotine replacement therapy and can be used in diverse populations... - Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: a randomized trialJoel A Simon
General Internal Medicine Section, Department of Veterans Affairs Medical Center, San Francisco, California 94121, USA
Am J Med 114:555-62. 2003.... - The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS)Joel A Simon
General Internal Medicine Section, Medical Service, Veterans Affairs Medical Center, and Department of Epidemiology and Biostatistics, School of Medicine, University of California, San Francisco 94121, USA
Ann Epidemiol 16:138-45. 2006..To determine whether baseline serum uric acid (UA) levels and estrogen-progestin (E+P)-associated change in serum UA in postmenopausal women with coronary disease are associated with recurrent coronary heart disease (CHD) events... - Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) StudyJoel A Simon
General Internal Medicine Section, Medical Service, Veterans Affairs Medical Center, San Francisco, California, USA
Am J Cardiol 97:843-50. 2006..The magnitude of the lipid and lipoprotein responses, however, differed among participants according to a number of phenotypic and demographic characteristics... - Relation of serum ascorbic acid to Helicobacter pylori serology in US adults: the Third National Health and Nutrition Examination SurveyJoel A Simon
General Internal Medicine Section 111A1, Medical Service, San Francisco Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
J Am Coll Nutr 22:283-9. 2003..Because race appeared to modify the association between serum ascorbic acid and seropositivity to H. pylori, we conducted the analyses stratified by race... - Relation of ascorbic acid to coronary artery calcium: the Coronary Artery Risk Development in Young Adults StudyJoel A Simon
General Internal Medicine Section 111A1, Medical Service, Veterans Affairs Medical Center and University of California, 4150 Clement Street, San Francisco, CA 94121, USA
Am J Epidemiol 159:581-8. 2004..Low to marginally low plasma ascorbic acid levels were associated with a higher prevalence of coronary artery calcium among men but not among women... - Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary diseaseDavid M Herrington
Department of Internal Medicine, Sections on Cardiology, Wake Forest University School of Medicine, Winston Salem, NC 27157 1040, USA
Arterioscler Thromb Vasc Biol 22:1012-7. 2002..If factor V Leiden genotyping becomes less expensive, it could be cost effective to screen for the presence of the mutation before instituting HRT in women with coronary disease... - Combined vitamin E and vitamin C supplement use and risk of cardiovascular disease mortalityJoel A Simon
Arch Intern Med 162:2630; author reply 2630. 2002 - Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learnedCurt D Furberg
Wake Forest University School of Medicine, Winston Salem, NC 27157 1063, USA
Circulation 105:917-22. 2002..We analyzed the HERS data to determine whether there were specific subgroups of women who responded differently to treatment, either during the first year or in the overall study... - Differential effects of ramipril on ambulatory blood pressure in African Americans and CaucasiansAndrew Moran
Department of Medicine, University of California at San Francisco, and San Francisco General Hospital, California, USA
Am J Hypertens 20:884-91. 2007..Past studies did not compare daytime and nighttime ambulatory blood-pressure responses to angiotensin-converting enzyme inhibitors in African Americans and Caucasians... - Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health InitiativeRandi L Wolf
Program in Nutrition, Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY 10027, USA
Am J Clin Nutr 82:581-8. 2005..Antioxidant defenses are one possible mechanism for decreasing oxidative damage and its potentially negative effects on age-related bone mass... - Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatmentRonald M Krauss
Children s Hospital Oakland Research Institute, 5700 Martin Luther King Jr Way, Oakland, CA 94609, USA
Circulation 117:1537-44. 2008..We hypothesized that single nucleotide polymorphisms in the gene encoding HMGCR, a rate-limiting enzyme in cholesterol synthesis and the direct enzymatic target of statins, contribute to variation in statin response... - Hostility predicts recurrent events among postmenopausal women with coronary heart diseaseLily A Chaput
Department of Epidemiology and Biostatistics, School of Medicine, University of California San Francisco, 94115, USA
Am J Epidemiol 156:1092-9. 2002..In this study, hostility was found to be an independent risk factor for recurrent CHD events in postmenopausal women... - Clinical trials of uric acid lowering for coronary heart disease risk reductionJoel A Simon
Am J Med 119:e5; author reply e7. 2006